FILE - This image provided by Novo Nordisk in January 2023, shows packaging for the company's Wegovy drug. Even as millions of older adults clamor for drugs such as Ozempic and Wegovy, monthly use of the medications known as GLP-1 receptor agonists soared nearly 600% between 2020 and 2023 in people under 25 – and as young as 12. (Novo Nordisk via AP, File)